Pandemic effect: 7 out of 10 Argentines said they would volunteer for clinical trial

Pandemic effect: 7 out of 10 Argentines said they would volunteer for clinical trial

According to a survey by the Argentine Chamber of Medical Specialties, the knowledge of clinical trials and the key role played by the public has increased by 50% due to the advent of the coronavirus.

Picture of the first participant in clinical trials of Pfizer and BioNTech Covid-19 vaccine.  File photo.
Picture of the first participant in clinical trials of Pfizer and BioNTech Covid-19 vaccine. File photo.

Seven out of 10 Argentines said they would volunteer for a clinical trial for a vaccine or medical treatment.. The data comes from a survey conducted in November by the Argentine Chamber of Medical Specialties.Leave me). Prior to the pandemic, the number of people willing to participate in scientific research in the country was 50% less.

It seems that the coronavirus and its consequences have fully affected the will of the people. Sampling of the chamber was done at the national level, Online, November 19 and 26, 2021, and included 850 men and women between the ages of 16 and 65.

The poll showed an 83% consensus In which the development of clinical trials is positive for the country. In general, participants believed that the studies would benefit all participants, although public opinion is that pharmaceutical companies are more supportive than patients; 80% believe it is largely or fairly brought to healthcare facilities, 78% to patients, 76% to healthcare professionals, 75% to the general population and 65% to the country’s economy.

Another result of that The survey showed that 30% of the consultants said they had enough or a lot of information about clinical trials. This represents an increase of more than 50%. Compared to the pre-pandemic era, where only 18% said they knew what the trials were about and how they were conducted. Another finding of the study concerned sources of information. In the age of social media and Information with one click, 73% named a physician as the primary source for review of clinical trials.

The question was also asked under what circumstances they would participate in the study and whether they would volunteer for this work when seeking treatment or cure for serious / terminal illnesses or who are currently untreated. In this case, 6 out of 10 said they would participate even if they were healthy “Helping Science Advancement,” seen in part by thousands of volunteers enrolled in the Covid-19 vaccine study.

In addition, including consultations, 8 out of 10 knew that volunteers were signing informed consent, but 31% did not know that they could withdraw from the survey at any time. Meanwhile, 81% said they knew the role National Administration of Medicines, Food and Medical Technologies (Anmat) And strict and standardized regulation of international protocols, 78%. However, almost 4 in 10 were unaware that these studies were also approved and overseen by independent ethics committees.

“Democratization of information”, one of the keys

After learning of the results, Georgina Spossetti, who is the doctor, director and founder of “Essay for Me”, a site that brings together all the tests performed on various diseases, said the knowledge helps patients and volunteers to get down. Myths. “It is the democratization of information in a friendly language, the provision of tools for patients to be able to independently assess their ability to participate in clinical trials. “The disease can be an opportunity, you just have to find one and participate in a clinical trial can be one of them.”

For her part, Susanna Baldini, Medical Director of Caeme, which integrates innovative pharmaceutical laboratories and research organizations through the Argentine Chamber of Clinical Research Organizations (Caoic), added: “For a long time we wanted to have a clearer question about what people actually think about clinical trials. Because we believed in misinformation and superstition “They have surpassed data, the strength of medical advances, and the growing prevalence of this practice.”

Baldin said the results served to understand what it is Important: “Developing an information campaign on clinical trials, its scope, processes, and old myths refutes the evidence, because the more information there is, the more empowerment there is. “Less superstition and more faith in the value of the people and the country.”

Meanwhile, Spossetti spoke about the importance of independent evaluations being made to avoid changes to essays. “The independent evaluation carried out by these interdisciplinary committees prevents any deviation from the procedures. Both voluntarily and involuntarily. The safety of participants is always and should be a priority as it is what quietly gives to enrollees, researchers, all involved and the community as a whole.

For her part, Carina de Lazar, president of Caoic, recalls: “While it is not a risk-free activity to test a certain molecule in humans, This has already gone through preclinical phases in the laboratory where its safety has been rigorously tested so that the risk-benefit equation is positive and the phases Further studies allow us to prove the initial hypothesis that it offers benefits that are known in terms of both safety and efficacy. ”

Source: La Nacion